Associate Professor Emily BlythResearch Lead at CCR - Cell Therapies - BMT Cell Therapies

 Emailemily.blyth(at)sydney.edu.au

Associate Professor Blyth is a blood stem cell transplant physician and haematologist at the Westmead Hospital Department of Haematology and the Clinical Lead for Immune Effector Cells in the Westmead Blood Transplant and Cell Therapies Program. 

Keywords

Haematological malignancy, Transplantation, Immunology

Themes

Cancer, Infection and Immunological Conditions

Clinical Specialty

Haematologist

Her research focus is the clinical application of T cell therapies in patients with cancers and the immune suppressing effects of cancer treatments. The ultimate aim of her research is to make transplant safer and more effective. She has been actively involved in the Cell Therapies Group’s clinical trial program since 2008. Given the success of T cell therapies for immune reconstitution and tumour control, she is currently investigating the biological effect of infused T cells in patients undergoing these treatments.

Faculty of Medicine and Health > Westmead Clinical School > Westmead Clinical School
Westmead Hospital > Department of Haematology > Blood Transplant and Cell Therapies Program

Associate Professor Blyth completed her undergraduate medical training at the University of Newcastle and postgraduate medical training at St Vincent’s Hospital and Westmead Hospital. In 2008, after obtaining her fellowships in clinical and laboratory haematology she commenced doctoral studies at the University of Sydney in the Cellular Therapies Group under the supervision of Professor David Gottlieb. She then continued to work with the group as a post-doctoral fellow with ongoing fellowship funding since 2008, including Ludwig Engel Post-Doctoral Fellowship, NHMRC Early Career Fellowship, Westmead Charitable Trust Early Career Grant Scheme, NSW Cancer Institute Early Career Fellowship and NSW Office of Health and Medical Research Gene and Cell Therapy EMCR Fellowship.